Department of Hematology

Hematology Home >

Faculty

Leslie A Fecher, MD

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Department: Medicine

Contact information

3400 Spruce St
16 Penn Tower
Philadelphia, PA 19104

Office: 215-662-7907
Fax: 215-662-4646

Email:
leslie.fecher@uphs.upenn.edu

Education:
BA (Biochemistry)
Rice University, 1996.
MD (Medicine)
Indiana University School of Medicine, 2000.

Post-Graduate Training
Internal Medicine Resident, University of Texas Southwestern, 2000-2003.
Medical Oncology Fellow, Johns Hopkins Unviersity, 2004-2007.

Certifications
American Board of Internal Medicine, Internal Medicine, 2003.
American Board of Internal Medicine, Medical Oncology, 2006.

Permanent link

> School of Medicine > Faculty > Details

Description of Clinical Expertise

Melanoma
Medical Oncology

Selected Publications

Carpenter EL, Mick R, Rech AJ, Beatty GL, Colligon TA, Rosenfeld MR, Kaplan DE, Chang KM, Domchek SM, Kanetsky PA, Fecher LA, Flaherty KT, Schuchter LM, Vonderheide RH.: Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers. Clin Cancer Res 15(13): 4277-87, July 2009.

Fecher LA, Amaravadi RK, Schuchter LM, Flaherty KT: Drug targeting of oncogenic pathways in melanoma. Hematol Oncol Clin North Am. David Fisher (eds.). 23(3): 599-618, June 2009.

Fecher LA and Flaherty KT: Where are we with adjuvant therapy of stage III and stage IV melanoma in 2009? J Natl Compr Canc Netw 7(3): 295-304, March 2009.

Fecher LA. : Overview of pathways in melanoma. Melanoma: Translational Research and Emerging Therapies, 1st edition. Agarwala, SS and Sondak VK. (eds.). Informa Healthcare. August 2008.

Fecher LA, Amaravadi RK, Schuchter, LM. : Effectively targeting BRAF in melanoma: a formidable challenge. Pigment Cell Melanoma Res 21(4): 410-411, August 2008.

Fecher L, Nathanson K, Flaherty K, Amaravadi R, Giles L, McGettigan S, Carberry M, Elder D, Schuchter L.: Phase I/II trial of imatinib and temozolomide in advanced unresectable melanoma. Proc. Amer. Soc. Clin. Oncol 26: abst 9059, May 2008.

Lange JR, Fecher LA, Sharfman WH, Alani RM, Mikkilineni R, Topalian SL, Balch CM : Melanoma. Abeloff’s Clinical Oncology 4th edition. Abeloff MD, Armitage J, Niederhuber J, Kastan M, McKenna W. (eds.). Elsevier Health Sciences: Churchill Livingstone, Page: 1229-1247, May 2008.

Fecher LA, Amaravadi RK, and Flaherty KT: The MAPK pathway in melanoma. Curr Opin Oncol. Jean Klastersky, MD (eds.). Lippincott Williams & Wilkins, 20(2): 183-189, March 2008.

Fecher LA, Sharfman WH. : Melanoma and other tumors of the skin. Current Cancer Therapeutics, 5th edition. Donehower RD and Ettinger DS. (eds.). Springer, 2008.

Fecher LA, Cummings SD, Keefe MJ, Alani RM.: Toward a Molecular Classification of Melanoma. Journal of Clinical Oncology 25(12): 1606-1620, April 2007.